IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MAGRINI, STEFANO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.961
AS - Asia 11.630
EU - Europa 9.469
SA - Sud America 2.612
Continente sconosciuto - Info sul continente non disponibili 539
AF - Africa 270
OC - Oceania 24
Totale 46.505
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.533
CN - Cina 3.970
SG - Singapore 3.803
UA - Ucraina 2.340
BR - Brasile 2.188
HK - Hong Kong 1.581
IT - Italia 1.512
DE - Germania 1.407
FR - Francia 822
FI - Finlandia 740
VN - Vietnam 740
PL - Polonia 553
IE - Irlanda 549
GB - Regno Unito 472
RU - Federazione Russa 471
TR - Turchia 441
IN - India 265
BD - Bangladesh 257
CA - Canada 198
AR - Argentina 149
SE - Svezia 127
MX - Messico 110
NL - Olanda 107
IQ - Iraq 101
EC - Ecuador 87
ZA - Sudafrica 83
ID - Indonesia 82
EE - Estonia 65
CO - Colombia 58
JP - Giappone 57
CZ - Repubblica Ceca 55
ES - Italia 46
UZ - Uzbekistan 44
PK - Pakistan 43
VE - Venezuela 42
MA - Marocco 38
SA - Arabia Saudita 36
BE - Belgio 33
PY - Paraguay 33
AT - Austria 31
TN - Tunisia 27
EG - Egitto 24
NG - Nigeria 24
EU - Europa 23
KE - Kenya 22
GR - Grecia 20
NP - Nepal 20
AU - Australia 19
JM - Giamaica 19
JO - Giordania 19
CL - Cile 18
CR - Costa Rica 18
LT - Lituania 17
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 16
IL - Israele 16
MY - Malesia 16
PE - Perù 14
DO - Repubblica Dominicana 13
HN - Honduras 13
PA - Panama 13
BO - Bolivia 12
CH - Svizzera 12
OM - Oman 12
DZ - Algeria 11
PH - Filippine 11
SN - Senegal 11
TT - Trinidad e Tobago 11
AL - Albania 10
BY - Bielorussia 10
KZ - Kazakistan 10
TH - Thailandia 10
BG - Bulgaria 9
IR - Iran 9
KG - Kirghizistan 9
UY - Uruguay 9
DK - Danimarca 8
HU - Ungheria 8
SV - El Salvador 8
BB - Barbados 7
LA - Repubblica Popolare Democratica del Laos 7
LB - Libano 7
LV - Lettonia 7
PT - Portogallo 7
ET - Etiopia 6
KR - Corea 6
KW - Kuwait 6
MU - Mauritius 6
GT - Guatemala 5
RS - Serbia 5
MK - Macedonia 4
NZ - Nuova Zelanda 4
PR - Porto Rico 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UG - Uganda 4
AO - Angola 3
CI - Costa d'Avorio 3
GE - Georgia 3
HR - Croazia 3
Totale 45.941
Salva come PNG Salva come JPEG
Città #
Singapore 1.958
Ashburn 1.805
Jacksonville 1.787
Fairfield 1.744
Woodbridge 1.608
Hong Kong 1.575
Houston 1.169
San Jose 979
Ann Arbor 899
Chandler 806
Princeton 806
Cambridge 777
The Dalles 770
Beijing 745
Wilmington 703
Seattle 700
Nanjing 579
Dublin 545
Warsaw 541
Council Bluffs 508
New York 487
Los Angeles 438
Lauterbourg 374
Helsinki 372
Istanbul 367
Columbus 345
Dearborn 268
Dallas 256
Ho Chi Minh City 249
Buffalo 222
Nanchang 219
Milan 210
Des Moines 202
Moscow 198
São Paulo 196
Munich 171
Changsha 152
Brescia 150
Shenyang 139
Hanoi 132
Hebei 125
San Diego 122
Shanghai 122
Tianjin 120
San Francisco 119
Jinan 117
Santa Clara 113
Chicago 103
Orem 95
Jiaxing 89
Redondo Beach 76
Rio de Janeiro 75
Rome 69
Kunming 65
London 65
Tallinn 65
Verona 64
Hangzhou 61
Dong Ket 56
Phoenix 53
Washington 52
Boardman 51
Brooklyn 51
Montreal 51
Tokyo 50
Toronto 48
Turku 48
Zhengzhou 48
Nuremberg 47
Brasília 46
Denver 46
Frankfurt am Main 45
Belo Horizonte 44
Guangzhou 44
Chennai 43
Lancaster 40
Tashkent 40
Atlanta 38
Johannesburg 38
Quito 38
Brno 37
Curitiba 34
Jakarta 34
Ningbo 34
Haiphong 33
Lanzhou 33
Dhaka 32
Brussels 31
Da Nang 31
Mexico City 31
Norwalk 31
Taizhou 31
Augusta 30
Poplar 29
Porto Alegre 29
Baghdad 28
Boston 28
Manchester 28
Paris 28
Amsterdam 27
Totale 29.452
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 501
Low dose rate brachytherapy (LDR-BT) as monotherapy for early stage prostate cancer in Italy: practice and outcome analysis in a series of 2237 patients from 11 institutions 283
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 275
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: the Pros-IT CNR study 254
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 252
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 232
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 228
Pros-IT CNR: an Italian prostate cancer monitoring project 226
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 226
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 222
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 214
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 213
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 213
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 213
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 202
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 199
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 196
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 196
GUROPA survey: genito-urinary radiation oncology prescription attitudes 196
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factors 194
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 191
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 191
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 187
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part I: evolving technical choices and survival 186
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 184
THE ROLE OF PRIMARY SURGERY AND EXTERNAL BEAM RADIATION THERAPY IN THE MANAGEMENT OF NON-METASTATIC DUCTAL PROSTATE CANCER: 20-YEAR OUTCOMES FROM A SINGLE INSTITUTION EXPERIENCE 180
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 180
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 179
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 179
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 178
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 178
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 177
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 177
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 175
Role of external beam radiotherapy in the treatment of relapsing meningioma 174
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 172
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 171
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society 170
From Molecular to Clinical Radiation Biology of Glioblastoma 170
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 170
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 169
The growing role of biology in the treatment of glioblastoma: no more one kind of disease 169
A benchmark study on 883 nasopharyngeal cancer patients treated in two Italian centres from 1977 to 2000. Part II: evolving technical choices and toxicity patterns 167
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 167
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 167
Stereotactic radiotherapy with simultaneous integrated protection planning technique for synovial sarcoma with stomach abutment: A case report of a complete response 166
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 166
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 165
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 163
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 163
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 163
Could Concomitant Radio-Chemotherapy Improve the Outcomes of Early-Stage Node Negative Anal Canal Cancer Patients? A Retrospective Analysis of 122 Patients 162
Could Machine Learning Improve the Prediction of Pelvic Nodal Status of Prostate Cancer Patients? Preliminary Results of a Pilot Study 162
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 161
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 161
Carboplatin (JM8), etoposide (VP16) and thoracic Irradiation for small cell lung cancer (S.C.L.C.): An evaluation of lung toxicity 160
"Radiotherapy versus combined modality in early stages", 159
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 159
Caveolin-1 promotes radioresistance in rhabdomyosarcoma through increased oxidative stress protection and DNA repair 159
Open-source, low cost, high-reliability solutions for digital imaging systrems: example of a dicom router/Soluzioni Open Source per sistemi Low Cost e High Reliability per l'imaging digitale: l'esempio di un dicom router. 158
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 158
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 158
Predictive factors for oropharyngeal mycosis during radiochemotherapy for head and neck carcinoma and consequences on treatment duration. Results of mycosis in radiotherapy (MIR): A prospective longitudinal study 157
Patterns of practice and survival in a retrospective analysis of 1722 adult astrocytoma patients treated between 1985 and 2001 in 12 italian radiation oncology centers 156
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 156
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 154
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 153
Extreme hypofractionation for early prostate cancer: Biology meets technology 151
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 150
Effects of fluconazole in the prophylaxis of oropharyngeal candidiasis in patients undergoing radiotherapy for head and neck tumour: results from a double-blind placebo-controlled trial. 149
A reappraisal of the role of PET and CT/PET in early stage Hodgkin's Disease (HD) in the experience of the florence and Brescia Universities. 149
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 149
Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series 148
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 148
Duration of androgen suppression in the treatment of prostate cancer 145
Cetuximab and Radiation Therapy in Head and Neck Cancer 145
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 145
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 144
A case report on how facing it problems: improving the reliability of a dicom router system through an affordable backup solution. 144
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 144
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma 144
Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy 144
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 144
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 143
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 142
Postoperative radiotherapy after radical prostatectomy for prostate carcinoma: the experience of the Brescia Radium Institute. 140
Short fractionation radiotherapy for early prostate cancer in the time of COVID-19: long-term excellent outcomes from a multicenter Italian trial suggest a larger adoption in clinical practice 140
Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study. 139
Information Retrieval in Medicine: an Extensive Experimental Study 139
18F-FDG-PET/CT in laryngeal cancer: Comparison with conventional imaging and prognostic role 139
"CHEMOTHERAPY VERSUS RADIOTHERAPY IN EARLY-STAGE HODGKIN'S DISEASE: EVIDENCE OF A MORE DIFFICULT RESCUE FOR PATIENTS RELAPSED AFTER CHEMOTHERAPY" 138
Exploiting Machine Learning for Predicting Nodal Status in Prostate Cancer Patients 138
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR study 137
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 136
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 136
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 136
Second malignancies in Hodgkin's disease 135
Reliability of prostate-specific antigen-marker in determining biochemical failure during the first 2 years after external beam radiation therapy and hormone therapy in patients with non-operated prostate cancer. 135
Radiotherapy in case of locally advanced prostate cancer: long-term follow-up in 223 patients 135
Radiation Tolerance of Normal Brain: QUANTEC 2010 and Beyond 135
Totale 17.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 238.073
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 238.073
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.013 0 0 47 104 44 137 113 211 155 305 229 668
2022/20232.483 449 133 72 160 173 638 8 236 305 143 83 83
2023/20242.909 131 48 253 129 119 529 91 116 826 67 81 519
2024/20256.457 44 80 35 801 819 557 714 184 557 511 1.296 859
2025/202612.935 1.172 1.913 1.118 2.165 1.102 753 1.756 454 839 961 480 222
2026/20271.952 634 621 697 0 0 0 0 0 0 0 0 0
Totale 46.505